BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36349480)

  • 21. EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis.
    Guarana M; Nouér SA; Nucci M
    Mycoses; 2021 Dec; 64(12):1542-1545. PubMed ID: 34013538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.
    Fernández-Cruz A; Semiglia MA; Guinea J; Martínez-Jiménez MDC; Escribano P; Kwon M; Rodríguez-Macías G; Chamorro-de-Vega E; Rodríguez-González C; Navarro R; Galar A; Sánchez-Carrillo C; Díez-Martín JL; Muñoz P
    Med Mycol; 2020 Apr; 58(3):300-309. PubMed ID: 31231772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases.
    Dellière S; Guitard J; Sabou M; Angebault C; Moniot M; Cornu M; Hamane S; Bougnoux ME; Imbert S; Pasquier G; Botterel F; Garcia-Hermoso D; Alanio A
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36044994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusariosis in cancer patients: 13 case series report and literature review.
    Cuervo-Maldonado SI; Álvarez-Rodríguez JC; Cubides CL; Barrera JC; Montañez-Abril JD; Vergara-Vela EP; Saavedra-Trujillo CH; López-Mora MJ; Mora-Figueroa GE; Celis-Ramírez A; Jaramillo-Calle RM; Parra-Medina R
    Biomedica; 2023 Aug; 43(Sp. 1):41-56. PubMed ID: 37721903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated fusariosis in a child after haploidentical hematopoietic stem cell transplantation.
    Hoshino A; Tokoro S; Akashi T; Inoue M; Takagi M; Imai K; Kanegane H; Muraosa Y; Kamei K; Morio T
    Pediatr Int; 2020 Mar; 62(3):419-420. PubMed ID: 32246571
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.
    Nucci M; Anaissie EJ; Queiroz-Telles F; Martins CA; Trabasso P; Solza C; Mangini C; Simões BP; Colombo AL; Vaz J; Levy CE; Costa S; Moreira VA; Oliveira JS; Paraguay N; Duboc G; Voltarelli JC; Maiolino A; Pasquini R; Souza CA
    Cancer; 2003 Jul; 98(2):315-9. PubMed ID: 12872351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation.
    Nambiar P; Cober E; Johnson L; Brizendine KD
    Transpl Infect Dis; 2018 Jun; 20(3):e12872. PubMed ID: 29512240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis.
    Ichikawa S; Fukuhara N; Watanabe S; Okitsu Y; Onodera K; Onishi Y; Harigae H
    J Infect Chemother; 2020 Feb; 26(2):292-295. PubMed ID: 31570321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.
    Alkhazraji S; Gebremariam T; Alqarihi A; Gu Y; Mamouei Z; Singh S; Wiederhold NP; Shaw KJ; Ibrahim AS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
    Raad II; Hachem RY; Herbrecht R; Graybill JR; Hare R; Corcoran G; Kontoyiannis DP
    Clin Infect Dis; 2006 May; 42(10):1398-403. PubMed ID: 16619151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current antifungal treatment of fusariosis.
    Al-Hatmi AMS; Bonifaz A; Ranque S; Sybren de Hoog G; Verweij PE; Meis JF
    Int J Antimicrob Agents; 2018 Mar; 51(3):326-332. PubMed ID: 28705676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.
    Yu J; Chen Y; Fang J; Zhang K
    Medicine (Baltimore); 2019 Jun; 98(26):e16246. PubMed ID: 31261588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
    Rossato L; Carlesse F; Nobrega de Almeida J; Kontoyiannis DP; Colombo AL
    Curr Opin Infect Dis; 2021 Dec; 34(6):619-626. PubMed ID: 34751181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated Bisifusarium infection following toxic epidermal necrolysis in a child with B-cell acute lymphoblastic leukemia.
    Brent G; Abdul-Wahab A; Borman AM; Ferguson L; Ferreras-Antolin L; Ho B; Johnson EM; Mashhoudi Y; van Rijswijk E; Wijesuriya N; Mansoor N
    Pediatr Dermatol; 2023; 40(3):503-506. PubMed ID: 36334032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive Fusariosis: A Single Pediatric Center 15-Year Experience.
    Schwartz KL; Sheffield H; Richardson SE; Sung L; Morris SK
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):163-70. PubMed ID: 26407418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
    Klingspor L; Saaedi B; Ljungman P; Szakos A
    Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.
    Candoni A; Aversa F; Busca A; Cesaro S; Girmenia C; Luppi M; Rossi G; Venditti A; Nosari AM; Pagano L
    J Chemother; 2015 Feb; 27(1):1-12. PubMed ID: 25466728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.
    Boutati EI; Anaissie EJ
    Blood; 1997 Aug; 90(3):999-1008. PubMed ID: 9242529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated cutaneous fusariosis in an immunocompetent patient.
    Kao YC; Stevenson PH; Kong FW; Lee KJ; McMeniman EK
    Australas J Dermatol; 2022 Feb; 63(1):130-131. PubMed ID: 34529825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.